A mathematical model of venous neointimal hyperplasia formation
暂无分享,去创建一个
Avner Friedman | Christopher Valentine | A. Friedman | B. Rovin | R. Schugart | A. Agarwal | Brad H Rovin | Richard C Schugart | Paula Budu-Grajdeanu | Richard C. Schugart | Anil K Agarwal | C. Valentine | Paula Budu-Grajdeanu
[1] Y. Miyachi,et al. Expression of basic fibroblast growth factor and its receptor by fibroblast, macrophages and mast cells in hypertrophic scar. , 1999, European journal of dermatology : EJD.
[2] Prabir Roy-Chaudhury,et al. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. , 2006, Journal of the American Society of Nephrology : JASN.
[3] G. Heine,et al. Is AV Fistula Patency Associated with Angiotensin-Converting Enzyme (ACE) Polymorphism and ACE Inhibitor Intake? , 2004, American Journal of Nephrology.
[4] T. Dix,et al. Redox-mediated activation of latent transforming growth factor-beta 1. , 1996, Molecular endocrinology.
[5] P. Singhal,et al. Leukocyte-polytetrafluoroethylene interaction enhances proliferation of vascular smooth muscle cells via tumor necrosis factor-alpha secretion. , 1997, Kidney international.
[6] G. Heine,et al. Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients. , 2003, Kidney international.
[7] David R. Brown. Dependence of Neurones on Astrocytes in a Coculture System Renders Neurones Sensitive to Transforming Growth Factor \gb\1‐Induced Glutamate Toxicity , 1999, Journal of neurochemistry.
[8] L O,et al. A Mechanochemical Model for Adult Dermal Wound Contraction and the Permanence of the Contracted Tissue Displacement Profile , 1995 .
[9] R. Friedl,et al. Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. , 2002, Kidney international.
[10] M. Robbin,et al. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. , 2002, Kidney international.
[11] H. Feldman,et al. Hemodialysis vascular access morbidity. , 1996, Journal of the American Society of Nephrology : JASN.
[12] L. Antiga,et al. Radial artery wall shear stress evaluation in patients with arteriovenous fistula for hemodialysis access. , 2003, Biorheology.
[13] M. Karkkainen,et al. The Specificity of Receptor Binding by Vascular Endothelial Growth Factor-D Is Different in Mouse and Man* , 2001, The Journal of Biological Chemistry.
[14] G. Poli,et al. The lipid peroxidation end product 4‐hydroxy‐2,3‐nonenal up‐regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis 1 , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] M. Raftery,et al. Does the arteriovenous fistula in chronic haemodialysis patients stimulate endothelin-1 release? , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] E. Woodcock,et al. A LOW AFFINITY, LOW MOLECULAR WEIGHT ENDOTHELIN‐A RECEPTOR PRESENT IN NEONATAL RAT HEART , 1993, Clinical and experimental pharmacology & physiology.
[17] Gary R. Grotendorst. Chemoattractants and growth factors , 1992 .
[18] B. G. Brown,et al. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. , 1989, Circulation.
[19] M. Daemen,et al. Intimal hyperplasia in vascular grafts. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[20] M. F. Weiss,et al. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] T. Masaki,et al. Pathophysiology of endothelin in the cardiovascular system. , 1999, Annual review of physiology.
[22] I. K. Cohen,et al. Wound Healing: Biochemical & Clinical Aspects , 1992 .
[23] R. Moritz,et al. Biosynthesis of Vascular Endothelial Growth Factor-D Involves Proteolytic Processing Which Generates Non-covalent Homodimers* , 1999, The Journal of Biological Chemistry.
[24] D. Windus. Permanent vascular access: a nephrologist's view. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] H. Lodish,et al. Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.
[26] C. Hehrlein. How do AV fistulae lose function? The roles of haemodynamics, vascular remodelling, and intimal hyperplasia. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[27] K. Porter,et al. Endothelin‐1 is a mediator of intimal hyperplasia in organ culture of human saphenous vein , 1997, The British journal of surgery.
[28] K. Kent,et al. The effect of growth factors, cytokines, and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells. , 2000, Journal of vascular surgery.
[29] David Roth,et al. Inflow stenosis in arteriovenous fistulas and grafts: a multicenter, prospective study. , 2005, Kidney international.
[30] S. Heffelfinger,et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. , 2001, Kidney international.
[31] V. Sukhatme,et al. Vascular access stenosis: prospects for prevention and therapy. , 1996, Kidney international.
[32] W. Border,et al. Transforming Growth Factor β in Tissue Fibrosis , 1994 .
[33] E C Nice,et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF‐C/D receptor VEGFR‐3 , 2001, The EMBO journal.
[34] A. Dardik,et al. Arterial Wall Shear Stress: Observations from the Bench to the Bedside , 2003, Vascular and endovascular surgery.
[35] M. Aviram. LDL-Platelet Interaction Under Oxidative Stress Induces Macrophage Foam Cell Formation , 1995, Thrombosis and Haemostasis.
[36] J A Sherratt,et al. A mechanochemical model for adult dermal wound contraction and the permanence of the contracted tissue displacement profile. , 1995, Journal of theoretical biology.
[37] W. Border,et al. Transforming growth factor beta in tissue fibrosis. , 1994, The New England journal of medicine.